These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2285975)

  • 21. Antihypertensive effect of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride in rats.
    Wada K; Nakamura S; Morishita S; Kanda M; Matsui H; Fukata F; Shirahase H
    Arzneimittelforschung; 1994 Oct; 44(10):1112-6. PubMed ID: 7818582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
    Iqbal N; Akula MR; Vo D; Matowe WC; McEwen CA; Wolowyk MW; Knaus EE
    J Med Chem; 1998 May; 41(11):1827-37. PubMed ID: 9599233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 4-pyridyl and 3-arylethyloxycarbonyl substituents.
    Akula MR; Matowe WC; Wolowyk MW; Knaus EE
    Drug Des Deliv; 1990 Dec; 7(1):11-7. PubMed ID: 2096831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-acting dihydropyridine calcium antagonists. 4. Synthesis and structure-activity relationships for a series of basic and nonbasic derivatives of 2-[(2-aminoethoxy)methyl]-1,4-dihydropyridine calcium antagonists.
    Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG
    J Med Chem; 1990 Feb; 33(2):585-91. PubMed ID: 2153819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-[4-(1-methoxycarbonyl-1,4-dihydropyridyl)]-3 ,5- pyridinedicarboxylates.
    Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
    Arch Pharm (Weinheim); 1999 Nov; 332(11):385-8. PubMed ID: 10605379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Synthesis of 2,6-dimethyl-4-disubstituted phenyl-1,4-dihydropyridine-3,5-dicarboxylates as antimyocardial ischemic agents].
    Yan ZM; Dong YM
    Yao Xue Xue Bao; 1991; 26(9):661-6. PubMed ID: 1821085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
    Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
    Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on nilvadipine. I. Synthesis and structure-activity relationships of 1,4-dihydropyridines containing novel substituents at the 2-position.
    Satoh Y; Ichihashi M; Okumura K
    Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3189-201. PubMed ID: 1814611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antihypertensive activities of 1,4-dihydropyridine-5-phosphonate derivatives. I.
    Morita I; Tada S; Kunimoto K; Tsuda M; Kise M; Kimura K
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3898-904. PubMed ID: 3435985
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis and calcium antagonistic activity of a new class of 1,4-dihydropyridines having an alkoxyimino group in position 3.
    Favara D; Nicola M; Pappalardo M; Bonardi G; Luca C; Marchini F; Sardi B
    Farmaco Sci; 1987 Oct; 42(10):697-708. PubMed ID: 3436440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long acting dihydropyridine calcium antagonists. 2. 2-[2-Aminoheterocycloethoxy]methyl derivatives.
    Arrowsmith JE; Campbell SF; Cross PE; Burges RA; Gardiner DG
    J Med Chem; 1989 Mar; 32(3):562-8. PubMed ID: 2918502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and crystal structure of optically active 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate (NZ-105).
    Sakoda R; Matsumoto H; Seto K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2377-81. PubMed ID: 1446358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Synthesis of alkyl 2,6-dimethyl-(substituted or unsubstituted furyl)-1,4-dihydropyridine-3,5-dicarboxylates].
    Zhang YH; Zhang ZQ; Wu Q
    Yao Xue Xue Bao; 1991; 26(5):375-8. PubMed ID: 1957689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular tools for the study of calcium channels: synthesis and evaluation of biological activity of new derivatives of 4-aryl-1,4-dihydropyridine groups].
    Soldatov NM
    Biokhimiia; 1988 Jul; 53(7):1059-68. PubMed ID: 2846077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dihydropyrimidine calcium channel blockers. 2. 3-substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines.
    Atwal KS; Rovnyak GC; Kimball SD; Floyd DM; Moreland S; Swanson BN; Gougoutas JZ; Schwartz J; Smillie KM; Malley MF
    J Med Chem; 1990 Sep; 33(9):2629-35. PubMed ID: 2391701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
    Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
    Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines.
    Atwal KS; Rovnyak GC; Schwartz J; Moreland S; Hedberg A; Gougoutas JZ; Malley MF; Floyd DM
    J Med Chem; 1990 May; 33(5):1510-5. PubMed ID: 2329573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of some 1,4-dihydropyridine derivatives and their calcium antagonistic activity.
    Safak C; Sahin I; Sunal R
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):119-22. PubMed ID: 2334450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on condensed 1,4-dihydropyridine derivatives and their calcium modulatory activities.
    Aydin F; Safak C; Simşek R; Erol K; Ulgen M; Linden A
    Pharmazie; 2006 Aug; 61(8):655-9. PubMed ID: 16964703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central interactions between dihydropyridines and cholinergic systems in the control of blood pressure in rat.
    Brisac AM; Huguet F; Champeroux P; Montastruc JL; Lucet B; Gerard P; Laurent S; Narcisse G; Schmitt H
    Brain Res; 1987 Dec; 435(1-2):160-6. PubMed ID: 2448012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.